Peer-reviewed veterinary case report
Oxidative stress levels measured in dogs with cancer using blood test
By Macotpet, Arayaporn et al.·Published in BMC veterinary research·2013·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Oxidative stress in cancer-bearing dogs assessed by measuring serum malondialdehyde.
- Species:
- dog
Plain-English summary
A group of 80 dogs with cancer had higher levels of a substance called malondialdehyde (MDA) in their blood, which indicates oxidative stress, compared to 101 healthy dogs. This suggests that oxidative stress may play a role in the development and progression of cancer in dogs. The cancer-bearing dogs also showed lower levels of red blood cells, hemoglobin, and packed cell volume, while their white blood cell counts were higher. Understanding these changes can help veterinarians assess the health of dogs with cancer and tailor their treatment plans accordingly.
People also search for: dog cancer symptoms · high MDA levels in dogs · oxidative stress in dogs · dog blood test results · cancer treatment for dogs
Abstract
BACKGROUND: Oxidative stress, an excess of reactive oxygen species (ROS), causes lipid peroxidation resulting in cell and tissue damages. It may be associated with the development and progression of cancers in dogs. Malondialdehyde (MDA), the end product of lipid peroxidation, is commonly used as a marker of oxidative stress. The objective of this study was to assess oxidative stress in cancer-bearing dogs by measuring serum MDA levels. All client-owned dogs underwent physical examination at the Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Khon Kaen University to determine the health status with the owner's consent. Blood samples of cancer-bearing dogs (N = 80) and clinically normal dogs (N = 101) were obtained and subjected for determination of MDA levels. In addition, complete blood count, creatinine, and alanine aminotransferase were measured. RESULTS: Serum MDA was significantly higher in cancer-bearing dogs than in clinically normal dogs (mean ± SD, 4.68 ± 1.32 μmol/L vs 2.95 ± 0.61 μmol/L, respectively; p < 0.001). Packed cell volume (mean ± SD, 36.18 ± 7.65% vs 44.84 ± 5.54%), hemoglobin (mean ± SD, 11.93 ± 2.88 g% vs 15.17 ± 2.00 g%) and red blood cells (median (IQA), 6.05 (2.15) vs 8.09 (1.34)) were all significantly lower in cancer-bearing dogs than in clinically normal dogs. However, the reverse was true for white blood cells (median (IQA), 18.20 (11.95) vs 14.90 (5.10)). Neither creatinine nor alanine aminotransferase levels were significantly different between groups. CONCLUSIONS: This study supports the conclusion that oxidative stress is associated with many types of cancers in dogs, as serum MDA levels were significantly higher in cancer-bearing dogs compared to clinically normal dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23663727/